Sphingosine kinase type 1 inhibitors, and processes for using same
US8314151B2 · kind B2 · utility
18Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2009 |
| Grant date | Nov 20, 2012 |
| Priority date | — |
| Expiry date | Aug 31, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel compositions and analogs which are useful in a number of applications, indications and diseases, as well as for monitoring pharmakinetics and patient management. These compounds and analogs are applicable to treating tumors of the central nervous system, e.g., glioblastoma (GBM).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.